Data Partnerships Lead

San Francisco, California, United States

Apply with AI Apply

$150,000 – $180,000Compensation

Expert & Leadership (9+ years)Experience Level

Full TimeJob Type

UnknownVisa

Artificial Intelligence, Medicine, Biotechnology, SoftwareIndustries

Requirements

Candidates should have at least 4 years of experience in the pharmaceutical/biotech industry or a technology/technical services company within the pharmaceutical or healthcare sector. A strong understanding of clinical research and the general landscape of healthcare data is required, along with practical experience, determination, and autonomy to own projects end-to-end.

Responsibilities

The Data Partnerships Lead will collaborate with executives to define data strategies for product lines and indications, and drive the execution of data acquisition by negotiating agreements, pricing, and services. This role involves working with internal teams to define data requirements, evaluate data quality, and manage partnership projects, as well as surveying the data landscape to characterize opportunities for specific indications, products, or use cases.

Skills

Machine Learning

Generative AI

Clinical Trials

Data Partnerships

Storytelling

Teamwork

Experimentation

Problem-Solving

Unlearn AI

Creates AI-driven digital twins for healthcare

About Unlearn AI

Unlearn.AI creates digital twins of patients using artificial intelligence, which are virtual replicas that simulate potential health outcomes. This technology allows healthcare providers to predict how a patient's health may change over time, leading to more informed treatment decisions. The primary clients include healthcare providers and pharmaceutical companies, who can use these digital twins in clinical trials to simulate control groups, potentially speeding up drug development and approval processes. Unlearn.AI differentiates itself by offering a unique simulation technology that reduces the need for actual human control groups, which can save time and resources. The company's goal is to enhance decision-making in patient care and drug development through precise health outcome predictions.

San Francisco, CaliforniaHeadquarters

2017Year Founded

$127.1MTotal Funding

SERIES_CCompany Stage

AI & Machine Learning, HealthcareIndustries

51-200Employees

Benefits

Health Insurance

Dental Insurance

Vision Insurance

401(k) Retirement Plan

401(k) Company Match

Unlimited Paid Time Off

Paid Holidays

Commuter Benefits

Paid Parental Leave

Company Equity

Risks

Over-reliance on AI data may lead to inaccuracies in trial outcomes.

Increased competition from companies like Consilx and Aicure could impact market share.

High clinical trial failure rates could affect perception of Unlearn AI's effectiveness.

Differentiation

Unlearn AI's TwinRCT uses digital twins to enhance clinical trial precision.

The company offers TrialPioneer, a free tool for innovative trial design exploration.

Unlearn AI's digital twin technology reduces the need for human control groups.

Upsides

AI in clinical trials market expected to reach $2.74 billion by 2030.

Partnership with ProJenX highlights AI's potential in specific therapeutic areas.

TwinRCT 3.0 enhances decision-making in Phase II trials for better outcomes.

Land your dream remote job 3x faster with AI

Try Jobo Free